人类胚胎中的Cas9:在目标上但没有修复
1Danish National Research Foundation Center for Chromosome Stability, Department of Cellular and Molecular Biology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Cell
|December 11, 2020
概括
使用双链断裂的CRISPR-Cas9基因编辑导致90%以上的人类胚胎的染色体损失或错误修复. 这突显了基因手术应用的重大风险,原因是主要的结合修复途径.
科学领域:
- 分子生物学
- 遗传学
- 基因编辑技术
背景情况:
- CRISPR-Cas9是一个强大的基因编辑工具.
- 基因编辑旨在纠正遗传疾病.
- 了解Cas9引起的破坏后的修复机制至关重要.
研究的目的:
- 在人类胚胎中调查目标Cas9介导的双链断裂的结果.
- 评估Cas9活性后的基因修复途径的效率和准确性.
- 评估使用双链断裂用于人类胚胎治疗基因编辑的安全性和可行性.
主要方法:
- 使用CRISPR-Cas9技术在人类胚胎中诱导有针对性的双链断裂.
- 在Cas9诱导后分析染色体完整性和DNA修复结果.
- 量化了染色体丢失,错误修复和插入/删除的频率.
主要成果:
- 在90%以上的人类胚胎中,目标Cas9介导的双链断裂导致染色体损失或疾病等位基因的错误修复.
- 最终连接修复途径占主导地位,导致小插入或删除.
- 精确基因校正的效率显著下降.
结论:
- 在人体胚胎中,CRISPR- Cas9诱导的双链断裂导致高染色体异常和不精确的修复.
- 对于依赖双链断裂的治疗基因编辑策略来说,末端连接修复的占主导地位构成了重大挑战.
- 目前对人类胚胎进行"基因手术"的双链断裂存在重大风险和局限性.
更多相关视频
10:07A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
Published on: August 25, 2017
8.2K
09:03Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing
Published on: May 10, 2020
4.4K
相关概念视频
CRISPR
55.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
55.4K
In-vitro Mutagenesis
15.7K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
15.7K
Homologous Recombination
59.8K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
59.8K
